John D Shaughnessy

发表

The molecular classification of multiple myeloma.

John Crowley, Simona Colla, Bart Barlogie, 2006, Blood.

Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling

Bart Barlogie, B. Barlogie, J. Shaughnessy, 2003, Immunological reviews.

Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.

Bart Barlogie, F. Zhan, B. Barlogie, 2007, Blood.

Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.

Donna P Ankerst, Robin J Leach, Ian M Thompson, 2011, The Journal of urology.

Genetics and Cytogenetics of Multiple Myeloma

Bart Barlogie, Rafael Fonseca, Herve Avet-Loiseau, 2004, Cancer Research.

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.

Hongwei Xu, Wei Xiong, Simona Colla, 2007, Blood.

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

David R Williams, Bart Barlogie, Yongsheng Huang, 2006, Blood.

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3.

John Crowley, Pingping Qu, Bart Barlogie, 2011, Blood.

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2

David R Williams, Bart Barlogie, O. Stephens, 2010, Proceedings of the National Academy of Sciences.

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.

Anthony Boral, Paul Richardson, Yongsheng Huang, 2006, Blood.

Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.

Bart Barlogie, B. Barlogie, J. Shaughnessy, 2008, Blood.

Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray

F. Zhan, J. Shaughnessy, R. Katz, 2004, Modern Pathology.

Developing and Validating Continuous Genomic Signatures in Randomized Clinical Trials for Predictive Medicine

John Crowley, Pingping Qu, Shigeyuki Matsui, 2012, Clinical Cancer Research.

Absence Epilepsy in Tottering Mutant Mice Is Associated with Calcium Channel Defects

Richard Hawkes, Wayne N Frankel, Cathleen M Lutz, 1996, Cell.

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma.

Axel Benner, Thomas Hielscher, Bart Barlogie, 2008, Blood.

The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.

Bart Barlogie, Konstantinos Lefkimmiatis, James J Driscoll, 2010, Blood.

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor.

Bart Barlogie, Hartmut Goldschmidt, Dirk Hose, 2009, Blood.

The role of Dickkopf-1 in bone development, homeostasis, and disease.

J. Shaughnessy, T. Rosol, Y. Qiang, 2009, Blood.